Trial Profile
Pharmacokinetic interactions between elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat and telaprevir in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jan 2014
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Telaprevir
- Indications Hepatitis C; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 11 Jan 2014 New trial record